Delivery Order SPE2DB22D3401-SPE2DB24FT1XH
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award, identified as SPE2DB22D3102|SPE2DB24FL1BR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,217.40 firm-fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. The contract has a performance period through May 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $10,944.80, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 13, 2024. The contract is not designated with a set-aside requirement, indicating open...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,344.37 Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4,563,172,722 units of NARCAN 4 MG NASAL SPRAY 2S. This Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The $2,772.75 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $1,463.04 firm-fixed-price delivery order has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the Department of Defense (DoD) and Department of...
- This federal contract award, with ID SPE2DB22D1002|SPE2DB23FLGF7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $5,852.16 and an ultimate completion date of September 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- This contract award, with a ceiling value of $2,788.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The $4,593.74 firm-fixed-price delivery order has a completion date of January 5, 2023. This contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant...